Tralement trace elements 4 in 1 ML Injection

RxCUI
2693633
RxNorm name
Tralement trace elements 4 in 1 ML Injection
Display name
Tralement trace elements 4 in 1 ML Injection
Full name
Tralement trace elements 4 in 1 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TralementTRACE ELEMENTS INJECTION 4American Regent, Inc.a49ffb90-f307-433e-a86e-aaea6d6a99822024-07-01Warnings, Adverse reactionsExact identifier
rxcui: 2693633

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a49ffb90-f307-433e-a86e-aaea6d6a9982Tralement trace elements 4 in 1 ML Injection [PSN] · 1 ML copper sulfate 0.75 MG/ML / manganese sulfate 0.151 MG/ML / selenious acid 0.098 MG/ML / zinc sulfate 7.41 MG/ML Injection [Tralement] [SBD] · 1 ML copper sulfate 0.75 MG/ML / manganese sulfate 0.151 MG/ML / selenious acid 0.098 MG/ML / ZnSO4 7.41 MG/ML Injection [Tralement] [SY] · Tralement (copper sulfate 0.75 MG (copper 0.3 MG) / manganese sulfate 151 MCG (manganese 55 MCG) / selenious acid 98 MCG (selenium 60 MCG) / zinc sulfate 7.41 MG (zinc 3 MG)) per 1 ML Injection [SY]49These highlights do not include all the information needed to use TRALEMENT ® safely and effectively. See full prescribing information for TRALEMENT ® . TRALEMENT ® (trace elements injection 4* ) for intravenous use Initial U.S. Approval: 202020240701